Tianjin Ringpu Bio Tech (SHE:300119) — Stock Price
Tianjin Ringpu Bio Tech (SHE:300119) is currently trading at CN¥18.38 CNY, up 0.99% today. Over the past 52 weeks, shares have ranged between CN¥14.38 and CN¥23.48. This page tracks Tianjin Ringpu Bio Tech's live share price on the SHE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market cap of Tianjin Ringpu Bio Tech.
Tianjin Ringpu Bio Tech (300119) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Tianjin Ringpu Bio Tech's daily closing share price and trading volume on the SHE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Tianjin Ringpu Bio Tech Income Statement — Revenue, Profit & Earnings by Year
Tianjin Ringpu Bio Tech's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | CN¥3.40 Billion | CN¥3.07 Billion | CN¥2.71 Billion | CN¥2.08 Billion | CN¥2.01 Billion |
| Cost of Revenue | CN¥2.00 Billion | CN¥1.82 Billion | CN¥1.53 Billion | CN¥1.07 Billion | CN¥969.26 Million |
| Gross Profit | CN¥1.40 Billion | CN¥1.25 Billion | CN¥1.18 Billion | CN¥1.01 Billion | CN¥1.04 Billion |
| Research & Development | CN¥253.02 Million | CN¥206.65 Million | CN¥172.94 Million | CN¥132.68 Million | CN¥117.69 Million |
| SG&A | CN¥351.11 Million | CN¥188.94 Million | CN¥174.02 Million | CN¥142.82 Million | CN¥150.28 Million |
| Total Operating Expenses | CN¥2.96 Billion | CN¥876.70 Million | CN¥612.68 Million | CN¥592.90 Million | CN¥538.51 Million |
| Operating Income | CN¥441.81 Million | CN¥373.17 Million | CN¥569.75 Million | CN¥416.64 Million | CN¥499.36 Million |
| EBITDA | — | CN¥593.63 Million | CN¥736.66 Million | CN¥550.22 Million | CN¥596.07 Million |
| EBIT | — | CN¥401.24 Million | CN¥597.91 Million | CN¥442.77 Million | CN¥512.10 Million |
| Interest Expense | CN¥35.16 Million | CN¥32.95 Million | CN¥26.72 Million | CN¥28.96 Million | CN¥24.31 Million |
| Income Before Tax | CN¥470.69 Million | CN¥368.29 Million | CN¥571.19 Million | CN¥413.81 Million | CN¥487.79 Million |
| Income Tax Expense | — | CN¥38.46 Million | CN¥56.18 Million | CN¥40.04 Million | CN¥54.20 Million |
| Net Income | CN¥400.51 Million | CN¥300.72 Million | CN¥453.59 Million | CN¥346.70 Million | CN¥412.78 Million |
Tianjin Ringpu Bio Tech Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Tianjin Ringpu Bio Tech's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | CN¥7.66 Billion | CN¥7.97 Billion | CN¥6.60 Billion | CN¥6.11 Billion | CN¥5.69 Billion |
| Total Current Assets | CN¥3.37 Billion | CN¥3.65 Billion | CN¥3.26 Billion | CN¥3.09 Billion | CN¥3.06 Billion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | CN¥1.04 Billion | CN¥1.45 Billion | CN¥1.28 Billion | CN¥1.50 Billion | CN¥577.88 Million |
| Net Receivables | CN¥983.60 Million | CN¥1.14 Billion | CN¥1.02 Billion | CN¥742.53 Million | CN¥606.61 Million |
| Inventory | CN¥502.12 Million | CN¥499.57 Million | CN¥389.93 Million | CN¥367.06 Million | CN¥360.47 Million |
| Property, Plant & Equipment | — | — | — | — | CN¥1.30 Billion |
| Goodwill | CN¥442.99 Million | CN¥442.26 Million | CN¥67.80 Million | CN¥67.80 Million | CN¥67.80 Million |
| Total Liabilities | CN¥2.47 Billion | CN¥2.96 Billion | CN¥1.79 Billion | CN¥1.61 Billion | CN¥1.37 Billion |
| Total Current Liabilities | CN¥1.89 Billion | CN¥2.25 Billion | CN¥1.34 Billion | CN¥1.31 Billion | CN¥1.12 Billion |
| Long-term Debt | CN¥368.42 Million | CN¥513.81 Million | CN¥307.11 Million | CN¥191.18 Million | CN¥90.13 Million |
| Net Debt | CN¥502.83 Million | CN¥832.48 Million | CN¥536.67 Million | CN¥493.26 Million | CN¥-571.12 Million |
| Total Stockholder Equity | CN¥4.70 Billion | CN¥4.47 Billion | CN¥4.50 Billion | CN¥4.22 Billion | CN¥4.03 Billion |
| Retained Earnings | CN¥2.05 Billion | CN¥1.79 Billion | CN¥1.67 Billion | CN¥1.40 Billion | CN¥1.24 Billion |
Tianjin Ringpu Bio Tech Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Tianjin Ringpu Bio Tech generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | CN¥297.53 Million | CN¥735.55 Million | CN¥378.20 Million | CN¥389.49 Million | CN¥382.63 Million |
| Capital Expenditures | CN¥176.10 Million | CN¥185.34 Million | CN¥244.48 Million | CN¥372.43 Million | CN¥305.88 Million |
| Free Cash Flow | CN¥121.43 Million | CN¥550.21 Million | CN¥133.71 Million | CN¥17.05 Million | CN¥76.75 Million |
| Investing Cash Flow | — | CN¥-451.67 Million | CN¥-160.97 Million | CN¥-1.24 Billion | CN¥-627.06 Million |
| Financing Cash Flow | — | CN¥-133.28 Million | CN¥-272.46 Million | CN¥-48.35 Million | CN¥1.26 Billion |
| Dividends Paid | CN¥167.50 Million | CN¥215.78 Million | CN¥162.82 Million | CN¥163.69 Million | CN¥160.09 Million |
| Stock-Based Compensation | — | — | CN¥6.34 Million | CN¥4.37 Million | CN¥5.95 Million |
| Depreciation | CN¥223.61 Million | CN¥204.92 Million | CN¥141.04 Million | CN¥115.57 Million | CN¥91.57 Million |
| Change in Cash | CN¥149.29 Million | CN¥151.26 Million | CN¥-55.18 Million | CN¥-903.55 Million | CN¥1.02 Billion |
Tianjin Ringpu Bio Tech Earnings History — EPS Actual vs. Analyst Estimates
Track Tianjin Ringpu Bio Tech's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Apr 28, 2026 | 0.24 | — | — |
| Oct 25, 2025 | 0.23 | — | — |
| Aug 26, 2025 | 0.31 | — | — |
| Apr 02, 2025 | 0.12 | — | — |
| Oct 29, 2024 | 0.18 | — | — |
| Aug 24, 2024 | 0.16 | — | — |
| Apr 25, 2024 | 0.19 | — | — |
| Mar 29, 2024 | 0.39 | — | — |